{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:35:46Z","timestamp":1730871346470,"version":"3.28.0"},"posted":{"date-parts":[[2023,12,13]]},"group-title":"In Review","reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,12,9]]},"abstract":"<title>Abstract<\/title><p>Purpose Chondrosarcoma (CSA) are mesenchymal tissue-derived bone tumors. CSA mainly occurs in older people. CSA has demonstrated resistance to chemotherapy and radiation; complete surgical removal with negative margins is the only treatment option. In the case of metastatic CSA, the chance of survival is meager. Since the conventional two-dimensional cell culture models failed to retain tumor characteristics, developing preclinical models mimicking the disease with the highest fidelity is paramount for personalized treatments. Methods In this study, we established spherical cultured cells as new models for CSA. First, we demonstrated that CSA cells could form spheroids when cultured in ultra-low attachment plates. Next, tissue samples from CSA patients were collected and processed into primary cells, which were subsequently cultured as primary spheroids. The growth rate of primary spheroids was monitored and the histology of mature spheroids were characterized. These primary spheroids were used in drug susceptibility studies where traditional doxorubicin therapy and our novel disulfiram-copper therapy were tested. Results Compared with conventional monolayer cultures, spheroids better recapitulated the features of the in vivo tumor in the aspect of the formation of extracellular matrix. In the drug susceptibility study, spheroids demonstrated high resistance to the classic therapies, suggesting that monolayer cultures may give false positive results. Therefore, using spheroids for drug research and development in the CSA field should provide more accurate results. Conclusion In summary, our study of primary CSA spheroids brought new insight into their chemoresistance and demonstrated its potential for personalized treatment of CSA in clinical medicine.<\/p>","DOI":"10.21203\/rs.3.rs-3728259\/v1","type":"posted-content","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T19:22:58Z","timestamp":1702495378000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-Derived Spheroid Culture Models Are Better Than Monolayer Models in Chondrosarcoma Research"],"prefix":"10.21203","author":[{"given":"Ruichen","family":"Ma","sequence":"first","affiliation":[{"name":"China-Japan Friendship Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Heim","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Schoedel","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt R.","family":"Weiss","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/0284186X.2018.1554260","article-title":"Chondrosarcoma in Norway 1990\u20132013; an epidemiological and prognostic observational study of a complete national cohort","volume":"58","author":"Thorkildsen J","year":"2019","unstructured":"Thorkildsen J, Taksdal I, Bjerkehagen B, et al. Chondrosarcoma in Norway 1990\u20132013; an epidemiological and prognostic observational study of a complete national cohort. Acta Oncol. 2019;58(3):273\u201382.","journal-title":"Acta Oncol"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B","article-title":"Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading","volume":"40","author":"Evans HL","year":"1977","unstructured":"Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40(2):818\u201331.","journal-title":"Cancer"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/230949901502300323","article-title":"Correlation between survival and tumour characteristics in patients with chondrosarcoma","volume":"23","author":"Kamal AF","year":"2015","unstructured":"Kamal AF, Husodo K, Prabowo Y, Hutagalung EU. Correlation between survival and tumour characteristics in patients with chondrosarcoma. J Orthop Surg (Hong Kong). 2015;23(3):365\u20139.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13569-018-0110-1","article-title":"Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment","volume":"8","author":"Lex JR","year":"2018","unstructured":"Lex JR, Evans S, Stevenson JD, et al. Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment. Clin Sarcoma Res. 2018;8:23.","journal-title":"Clin Sarcoma Res"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1302\/2058-5241.5.190052","article-title":"Chondrosarcomas in children and adolescents","volume":"5","author":"Puri A","year":"2020","unstructured":"Puri A. Chondrosarcomas in children and adolescents. EFORT Open Reviews. 2020;5(2):90\u20135.","journal-title":"EFORT Open Reviews"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11999-009-1056-7","article-title":"Surgical treatment of grade I central chondrosarcoma","volume":"468","author":"Donati D","year":"2010","unstructured":"Donati D, Colangeli S, Colangeli M, et al. Surgical treatment of grade I central chondrosarcoma. Clin Orthop Relat Res. 2010;468(2):581\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1302\/0301-620X.94B1.26876","article-title":"The treatment of locally recurrent chondrosarcoma: Is extensive further surgery justified?","volume":"94","author":"Streitbuerger A","year":"2012","unstructured":"Streitbuerger A, Ahrens H, Gosheger G, et al. The treatment of locally recurrent chondrosarcoma: Is extensive further surgery justified? J Bone Joint Surg Br. 2012;94(1):122\u20137.","journal-title":"J Bone Joint Surg Br"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura Y","year":"2015","unstructured":"Imamura Y, Mukohara T, Shimono Y, et al. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer. Oncol Rep. 2015;33(4):1837\u201343.","journal-title":"Oncol Rep"},{"year":"2019","author":"Wegert J","key":"ref9","unstructured":"Wegert J, Zauter L, Appenzeller S et al. 2019. High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro. Oncogene."},{"issue":"15","key":"ref10","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1002\/anie.201505062","article-title":"3D bioprinting of tissue\/organ models","volume":"55","author":"Pati F","year":"2016","unstructured":"Pati F, Gantelius J, Svahn HA. 3D bioprinting of tissue\/organ models. Angew Chem Int Ed. 2016;55(15):4650\u201365.","journal-title":"Angew Chem Int Ed"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.biotechadv.2016.11.002","article-title":"3D tumor spheroids: an overview on the tools and techniques used for their analysis","volume":"34","author":"Costa EC","year":"2016","unstructured":"Costa EC, Moreira AF, de Melo-Diogo D, et al. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol Adv. 2016;34(8):1427\u201341.","journal-title":"Biotechnol Adv"},{"issue":"6444","key":"ref12","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson D","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364(6444):952\u20135.","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.addr.2014.03.001","article-title":"3D cell culture systems modeling tumor growth determinants in cancer target discovery","volume":"69\u201370","author":"Thoma CR","year":"2014","unstructured":"Thoma CR, Zimmermann M, Agarkova I, et al. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev. 2014;69\u201370:29\u201341.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"e0181340","DOI":"10.1371\/journal.pone.0181340","article-title":"Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing","volume":"12","author":"Voissiere A","year":"2017","unstructured":"Voissiere A, Jouberton E, Maubert E, et al. Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing. PLoS ONE. 2017;12(7):e0181340.","journal-title":"PLoS ONE"},{"issue":"3","key":"ref15","first-page":"477","article-title":"Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research? Clin","volume":"479","author":"Ma R","year":"2021","unstructured":"Ma R, Mandell J, Lu F, et al. Do Patient-derived Spheroid Culture Models Have Relevance in Chondrosarcoma Research? Clin. Orthop Relat Res. 2021;479(3):477\u201390.","journal-title":"Orthop Relat Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"10732748211045274","DOI":"10.1177\/10732748211045274","article-title":"Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line DDCS2","volume":"28","author":"Li X","year":"2021","unstructured":"Li X, Dean DC, Ferreira A, et al. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line DDCS2. Cancer Control. 2021;28:10732748211045274.","journal-title":"Cancer Control"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.2147\/OTT.S112566","article-title":"Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time","volume":"9","author":"Baek N","year":"2016","unstructured":"Baek N, Seo OW, Kim M, et al. Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time. Onco Targets Ther. 2016;9:7207\u201318.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1440-1827.2010.02530.x","article-title":"Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas","volume":"60","author":"Dornauer K","year":"2010","unstructured":"Dornauer K, S\u00f6der S, Inwards CY, et al. Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas. Pathol Int. 2010;60(5):365\u201372.","journal-title":"Pathol Int"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<53::AID-CNCR8>3.0.CO;2-N","article-title":"Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma","volume":"79","author":"H\u00e4ckel C","year":"1997","unstructured":"H\u00e4ckel C, Czerniak B, Ayala AG, et al. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma. Cancer. 1997;79(1):53\u20138.","journal-title":"Cancer"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00418-012-1003-7","article-title":"\u03b21 integrins restrict the growth of foci and spheroids","volume":"138","author":"Gupta RK","year":"2012","unstructured":"Gupta RK, Johansson S. \u03b21 integrins restrict the growth of foci and spheroids. Histochem Cell Biol. 2012;138(6):881\u201394.","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00441-005-0148-2","article-title":"Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and beta1-integrin","volume":"324","author":"Lin R-Z","year":"2006","unstructured":"Lin R-Z, Chou L-F, Chien C-CM, Chang H-Y. Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and beta1-integrin. Cell Tissue Res. 2006;324(3):411\u201322.","journal-title":"Cell Tissue Res"},{"issue":"16","key":"ref22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10529-005-8652-8","article-title":"Role of E-cadherin molecules in spheroid formation of hepatocytes adhered on galactose-carrying polymer as an artificial asialoglycoprotein model","volume":"27","author":"Takei R","year":"2005","unstructured":"Takei R, Suzuki D, Hoshiba T, et al. Role of E-cadherin molecules in spheroid formation of hepatocytes adhered on galactose-carrying polymer as an artificial asialoglycoprotein model. Biotechnol Lett. 2005;27(16):1149\u201356.","journal-title":"Biotechnol Lett"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3892\/ijmm.2015.2114","article-title":"Integrin-\u03b21 regulates chondrocyte proliferation and apoptosis through the upregulation of GIT1 expression","volume":"35","author":"Zhang L-Q","year":"2015","unstructured":"Zhang L-Q, Zhao G-Z, Xu X-Y, et al. Integrin-\u03b21 regulates chondrocyte proliferation and apoptosis through the upregulation of GIT1 expression. Int J Mol Med. 2015;35(4):1074\u201380.","journal-title":"Int J Mol Med"},{"issue":"19","key":"ref24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.277003","article-title":"Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis","volume":"17","author":"Aszodi A","year":"2003","unstructured":"Aszodi A, Hunziker EB, Brakebusch C, F\u00e4ssler R. Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev. 2003;17(19):2465\u201379.","journal-title":"Genes Dev"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0046-8177(99)90066-7","article-title":"Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation","volume":"30","author":"Sato H","year":"1999","unstructured":"Sato H, Hasegawa T, Abe Y, et al. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation. Hum Pathol. 1999;30(11):1344\u20139.","journal-title":"Hum Pathol"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/annonc\/mdr512","article-title":"Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance","volume":"23","author":"van Oosterwijk JG","year":"2012","unstructured":"van Oosterwijk JG, Herpers B, Meijer D, et al. Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance. Ann Oncol. 2012;23(6):1617\u201326.","journal-title":"Ann Oncol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ygyno.2020.09.002","article-title":"The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration","volume":"159","author":"Gunay G","year":"2020","unstructured":"Gunay G, Kirit HA, Kamatar A, et al. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration. Gynecol Oncol. 2020;159(2):563\u201372.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11060-010-0357-8","article-title":"Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids","volume":"103","author":"Kolenda J","year":"2011","unstructured":"Kolenda J, Jensen SS, Aaberg-Jessen C, et al. Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids. J Neurooncol. 2011;103(1):43\u201358.","journal-title":"J Neurooncol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010311","article-title":"Chondrosarcoma: A rare misfortune in aging human cartilage? the role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic resistance","volume":"19","author":"Boehme KA","year":"2018","unstructured":"Boehme KA, Schleicher SB, Traub F, Rolauffs B. 2018. Chondrosarcoma: A rare misfortune in aging human cartilage? the role of stem and progenitor cells in proliferation, malignant degeneration and therapeutic resistance. Int J Mol Sci 19(1).","journal-title":"Int J Mol Sci"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3728259\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3728259\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T22:26:03Z","timestamp":1730845563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3728259\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":29,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3728259\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,12,13]]},"subtype":"preprint"}}